About [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate
[(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate (PubChem CID 58527817) has the molecular formula C36H34N2O5S
and a molecular weight of 606.74 g/mol. Its IUPAC name is [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate.
Molecular Properties
| Compound Name | [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate |
| PubChem CID | 58527817 |
| Molecular Formula | C36H34N2O5S |
| Molecular Weight | 606.74 g/mol |
| Exact Mass | 606.22 |
| IUPAC Name | [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate |
| SMILES | CCN1c2ccc(C(=O)/C(CCSc3c(C)cccc3C)=N/OC(C)=O)cc2Oc2cc(C(=O)c3ccccc3C)ccc21 |
| InChI | InChI=1S/C36H34N2O5S/c1-6-38-30-16-14-26(34(40)28-13-8-7-10-22(28)2)20-32(30)42-33-21-27(15-17-31(33)38)35(41)29(37-43-25(5)39)18-19-44-36-23(3)11-9-12-24(36)4/h7-17,20-21H,6,18-19H2,1-5H3/b37-29+ |
| InChIKey | KCRVOQQMDREQMH-SMTCOIIISA-N |
| XLogP | 8.39 |
| TPSA | 85.27 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 606.74 |
| LogP ≤ 5 | 8.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'het_666_B(3)', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate?
The IUPAC name of [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate (CID 58527817) is [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate.
What is the SMILES notation for [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate?
The canonical SMILES for [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate is CCN1c2ccc(C(=O)/C(CCSc3c(C)cccc3C)=N/OC(C)=O)cc2Oc2cc(C(=O)c3ccccc3C)ccc21.
What is the InChIKey of [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate?
The InChIKey is KCRVOQQMDREQMH-SMTCOIIISA-N. The full InChI is InChI=1S/C36H34N2O5S/c1-6-38-30-16-14-26(34(40)28-13-8-7-10-22(28)2)20-32(30)42-33-21-27(15-17-31(33)38)35(41)29(37-43-25(5)39)18-19-44-36-23(3)11-9-12-24(36)4/h7-17,20-21H,6,18-19H2,1-5H3/b37-29+.
What are the key properties of [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate?
[(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate has a molecular weight of 606.74 g/mol, XLogP of 8.39, 10 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [(E)-[4-(2,6-dimethylphenyl)sulfanyl-1-[10-ethyl-7-(2-methylbenzoyl)phenoxazin-3-yl]-1-oxobutan-2-ylidene]amino] acetate is sourced from PubChem (CID 58527817), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).